Cargando…
Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD
BACKGROUND: Beta-blockers are frequently withheld in patients with cardiovascular disease who also have chronic obstructive pulmonary disease (COPD) because of concerns that they might provoke bronchospasm and cause deterioration in health status. Although beta1-selective beta-blockers are associate...
Autores principales: | van Gestel, Yvette RBM, Hoeks, Sanne E, Sin, Don D, Stam, Henk, Mertens, Frans W, Bax, Jeroen J, van Domburg, Ron T, Poldermans, Don |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685144/ https://www.ncbi.nlm.nih.gov/pubmed/19516916 |
Ejemplares similares
-
Beta-blocker under-use in COPD patients
por: Lim, Kuan Pin, et al.
Publicado: (2017) -
Relation between regional and global systolic function in patients with ischemic cardiomyopathy after β-Blocker therapy or revascularization
por: Kaandorp, TAM, et al.
Publicado: (2010) -
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
por: Duffy, Sean, et al.
Publicado: (2017) -
Who's Afraid of the Big Bad Wolf? Safety of Beta-Blockers in COPD
por: Ambrosio, Giuseppe, et al.
Publicado: (2019) -
A secondary analysis of data from the OPTICARE randomized controlled
trial investigating the effects of extended cardiac rehabilitation on functional
capacity, fatigue, and participation in society
por: ter Hoeve, Nienke, et al.
Publicado: (2019)